Cargando…

Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) syndrome refractory to complete serum vascular endothelial growth factor (VEGF) blockade: insights from sequential VEGF monitoring

Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) syndrome is a systemic condition related to plasma cell dyscrasia. Increased vascular permeability is responsible for some of the hallmarks of this disorder that may include renal microangiopathy. Several lines of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guitard, Joëlle, Pillet, Adèle, Soubrier, Martin, Modesto, Anne, Chauveau, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421404/ https://www.ncbi.nlm.nih.gov/pubmed/25949341 http://dx.doi.org/10.1093/ndtplus/sfp094

Ejemplares similares

An Unfortunate Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Change (POEMS)
por: Afridi, Faraz, et al.
Publicado: (2017)

Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) syndrome complicated by ischemic stroke: A case report
por: Boostani, Reza, et al.
Publicado: (2018)

Kennedy Disease Misdiagnosed as Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome: A Case Report
por: Yuan, Min, et al.
Publicado: (2016)

POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes): A Case Report of a Rare Paraneoplastic Syndrome
por: Sakhuja, Anuradha, et al.
Publicado: (2022)

Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS syndrome): a paraneoplastic syndrome
por: Kumar, Sunil, et al.
Publicado: (2015)

Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report
por: Paranavitane, Shiran, et al.
Publicado: (2019)

Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome
por: Abdelahad, Mandi, et al.
Publicado: (2021)

POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome Masquerading as Chronic Inflammatory Polyradiculoneuropathy: A Case Report
por: Bayas, Angel, et al.
Publicado: (2022)

Atypical polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes syndrome without polyneuropathy: A case report
por: Li, Qiang, et al.
Publicado: (2020)

Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, and Skin Changes (POEMS) Syndrome and Idiopathic Portal Hypertension: A Rare Association
por: Belabbes, Fatima, et al.
Publicado: (2022)

Raynaud’s phenomenon and positive antinuclear antibodies as first manifestation of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes): a case report
por: Torres-Saavedra, Fabio, et al.
Publicado: (2022)

POEMS Syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy and Skin Changes) Treated with Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review
por: Arana, Carlos, et al.
Publicado: (2015)

Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone
por: Gao, Yajuan, et al.
Publicado: (2021)

Surgical revascularization for quasi-moyamoya disease associated with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome: a case report and literature review
por: Kubota, Yuki, et al.
Publicado: (2023)

Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes Associated With Castleman Disease: A Common Misdiagnosis
por: Palha, Vanessa, et al.
Publicado: (2021)

Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome
por: Suichi, Tomoki, et al.
Publicado: (2022)

Ischemic Stroke in a Patient With Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes Syndrome Treated With Lenalidomide
por: Sodavarapu, Soujanya, et al.
Publicado: (2020)

Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome With IgG Kappa/IgG Lambda Biclonal Gammopathy: A Rare Presentation of a Rare Disease
por: Mejia Buritica, Leonardo, et al.
Publicado: (2020)

First-line Usage of Daratumumab, Lenalidomide, Dexamethasone (DRd) Combination in a Case of Castleman Disease Variant of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome (CD-POEMS)
por: Sevindik, Omur Gokmen, et al.
Publicado: (2022)

POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, multiple myeloma and skin changes) with cranial vault plasmocytoma and the role of surgery in its management: a case report
por: Plata Bello, Julio, et al.
Publicado: (2013)

Successful stabilisation of nephropathy in a patient with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-band, skin changes) syndrome on treatment with mycophenolate and steroids: a case report
por: Rosser, Gareth J, et al.
Publicado: (2010)

Clinical and electrophysiological profiles in early recognition of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome
por: Wang, Qin, et al.
Publicado: (2019)

Polyneuropathy organomegaly endocrinopathy M-protein and skin changes syndrome with ascites as an early-stage manifestation: A case report
por: Zhou, Xiao-Lei, et al.
Publicado: (2023)

Effective treatment of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome with congestive heart failure: A case report
por: Fu, Ling-Yao, et al.
Publicado: (2021)

Development of Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome after Conversion from Plasmacytoma of Bone to Multiple Myeloma
por: Hatano, Keiko, et al.
Publicado: (2022)

Waldenstrom's Macroglobulinemia and Peripheral Neuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes with a Bleeding Diathesis and Rash
por: Haider, S., et al.
Publicado: (2013)

Adenopathy and extensive skin patch overlying plasmacytoma syndrome—the clue to early diagnosis of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes: A case series and literature review
por: Sanchez, Elizabeth Guevara, et al.
Publicado: (2022)

Unraveling the Neurological Complexity of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes Syndrome: A Report of a Challenging Case of a Young Woman and Cutting-Edge Advancements in the Field
por: Furciniti, Gioconda, et al.
Publicado: (2023)

Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome
por: Pihan, Morgane, et al.
Publicado: (2018)

Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report
por: Taenaka, Ryutaro, et al.
Publicado: (2022)

VEGF blockade damages brain vessels
por: Bashyam, Hema
Publicado: (2008)

Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015)

POEMS syndrome, calciphylaxis and focal segmental glomerulosclerosis – VEGF as a possible link
por: Heck, Dorothee, et al.
Publicado: (2014)

An update on the diagnosis and management of the polyneuropathy of POEMS syndrome
por: Cerri, Federica, et al.
Publicado: (2018)

Rapidly Progressive Polyneuropathy in a Patient With Monoclonal Gammopathy: A Case Report of POEMS Syndrome and Beyond
por: Wang, Chen, et al.
Publicado: (2016)

Tumor refractoriness to anti-VEGF therapy
por: Ribatti, Domenico
Publicado: (2016)

The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance
por: Alidzanovic, Lejla, et al.
Publicado: (2016)

Better prognosis in POEMS patients with cerebral infarction before polyneuropathy
por: Lan, Xiaoxi, et al.
Publicado: (2022)

VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody
por: Fushida, Sachio, et al.
Publicado: (2013)

Choroidal Neovascularization Regression on Fluorescein Angiography after VEGF Blockade
por: Do, Diana V., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_07clbpsubrg51u59nq36p89boe